Drug intelligence / Profile preview

maxing cough syrup

Development stage
Unknown
Lead developer
Guizhou Yibai Women's Pharmacy
Administration
Oral
01

Overview

maxing cough syrup (also known as Ma Xing Zhi Ke Tang Jiang) is an approved traditional Chinese medicine (TCM) syrup formulation developed and manufactured by Guizhou Yibai Women's Pharmacy (a subsidiary of Guizhou Yibai). It is derived from the classic TCM formula Ma Xing Shi Gan Decoction and is composed of four active herbal ingredients: Ephedra (*Ephedra sinica*), bitter apricot seed (*Prunus armeniaca*), gypsum, and licorice (*Glycyrrhiza uralensis*). The syrup is primarily indicated for the treatment of bronchitis, cough, phlegm, and wheezing. Its pharmacological action is mediated by the active alkaloids in Ephedra (such as ephedrine and pseudoephedrine) which act as adrenoceptor agonists to dilate bronchioles and relieve asthma, combined with the antitussive effects of amygdalin from bitter apricot seeds and the anti-inflammatory and expectorant properties of licorice.

Other names
Ma Xing Zhi Ke Tang JiangMaxing Cough Syrupmaxing zhike tangjiang麻杏止咳糖浆
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NET (Norepinephrine Transporter)PIK3R2 (PI3K regulatory subunit beta)ADRA1 (Alpha-1 adrenergic receptor family)ADRB1 (β1)

Beyond the preview

Go deeper on maxing cough syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on maxing cough syrup.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call